Summary: Psychedelics Today podcast host Kyle interviews MAPS researchers Michael and Annie Mithoefer for Vital Psychedelic Conversations. The Mithoefers are best known for their work supervising MAPS-sponsored Phase II trials of MDMA-assisted therapy for PTSD, our therapist training study, and a pilot study treating couples with MDMA-assisted therapy combined with cognitive behavioral conjoint therapy.
